On the reporting and analysis of a cancer evolutionary adaptive dosing trial
Crossref DOI link: https://doi.org/10.1038/s41467-020-20174-4
Published Online: 2021-01-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Mistry, Hitesh B. http://orcid.org/0000-0002-9683-1903
Text and Data Mining valid from 2021-01-12
Version of Record valid from 2021-01-12
Article History
Received: 29 April 2020
Accepted: 22 October 2020
First Online: 12 January 2021
Competing interests
: The author declares no competing interests.